Mode
Text Size
Log in / Sign up

How does conbercept help patients with macular edema from retinal vein occlusion?

high confidence  ·  Last reviewed May 25, 2026

Conbercept is a medication that blocks a protein called vascular endothelial growth factor (VEGF). In retinal vein occlusion (RVO), a blocked vein causes fluid to leak into the macula, the central part of the retina, leading to swelling (macular edema) and vision loss. By blocking VEGF, conbercept helps stop the leak, reduces swelling, and improves vision. It is given as an injection into the eye, usually every month for the first few doses, then as needed.

What the research says

Studies show conbercept effectively improves vision and reduces retinal swelling in patients with macular edema from RVO. A 2020 meta-analysis of 15 trials found that conbercept and another anti-VEGF drug, ranibizumab, produced similar improvements in vision and had similar safety profiles 4. Another study compared one initial injection of conbercept followed by injections as needed versus three monthly injections followed by as-needed treatment for branch RVO; both approaches led to similar gains in vision and reduction in central retinal thickness over 12 months 5. A 2024 trial in central RVO found that conbercept alone improved vision by an average of about 14.5 letters on an eye chart and reduced central retinal thickness by about 435 micrometers at 12 months 6. Adding dexamethasone (a steroid) to conbercept did not provide extra benefit 6. Blood pressure control also matters: a 2025 retrospective study found that patients with well-controlled blood pressure had better visual outcomes after conbercept injections than those with poorly controlled blood pressure 3.

What to ask your doctor

  • How many conbercept injections will I need initially, and how will we decide when to stop or continue?
  • Should I have my blood pressure checked and managed to get the best results from treatment?
  • What are the possible side effects of conbercept injections, such as infection or increased eye pressure?
  • Is conbercept a good option for me compared with other anti-VEGF drugs like ranibizumab or aflibercept?
  • How often will I need follow-up eye exams to monitor my vision and swelling?

This question is drawn from common patient questions about Ophthalmology and answered using cited medical research. We do not provide individualized advice.